Business updates7 Sep 2026 · 8:48 AM IST
MOREPENLABMorepen Laboratories
Finishes the first phase of its capacity expansion ahead of schedule
The company completed the first phase of its manufacturing capacity expansion early.
Price, Friday's close₹113.74▼ 3.16%
Last 5 days
What happened
- Morepen Laboratories completed the first phase of its manufacturing capacity expansion ahead of schedule.
Read the source
This is a summary of public news about Morepen Laboratories, for information only. It is not a recommendation to buy, sell or hold MOREPENLAB.
Morepen Laboratories in the news before
- 29 SEP 2026 · REGULATORYMorepen files its first US generic drug application, for diabetes drug sitagliptin